The 20 Best Monoclonal Gammopathy of Undetermined Significance (MGUS) Doctors Near Me in Washington, DC

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy. Dr. Kressel is board certified in American Board Of Internal Medicine.

Amarendra K Neppalli is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. K Neppalli is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Aarthi Shenoy is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Shenoy is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy. Dr. Boudadi is board certified in American Board Of Internal Medicine.

Dr. Sarah Waheed is a fellowship-trained oncologist specializing in the treatment of complex blood cancers including multiple myeloma, smoldering myeloma, amyloidosis, light chain disposition disease, monoclonal gammopathy (MGUS), POEMS and Waldenstrom’s macroglobulinemia. Her research on blood cancer treatments, transplant techniques and innovations are frequently published in peer-reviewed journals. As a member of the Johns Hopkins Kimmel Cancer Center’s blood cancers program at Sibley Memorial Hospital, Dr. Waheed is part of a team that is available 24/7 to evaluate, admit, diagnose and treat patients with same day appointments or through the emergency department. The Blood Cancer Program at Sibley is integrated with the Bone Marrow Transplant Program at The Johns Hopkins Hospital and can refer for stem cell transplant. Patients are able to receive care locally before and after the transplant. Dr. Waheed is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, and Schnitzler Syndrome. Dr. Waheed is board certified in American Board Of Internal Medicine.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia. Dr. Fishman is board certified in American Board Of Internal Medicine.

Robert Christie is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Christie is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).

Maria Chaudhry is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Chaudhry is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

Imadeddine Tabbara is a Hematologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 44 years. Dr. Tabbara is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.

Joseph Catlett is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Catlett is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.

Vera Malkovska is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Malkovska is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Sickle Cell Disease, and Bone Marrow Aspiration.

Kamyar Nader is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Nader is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Sickle Cell Disease, Follicular Lymphoma, and Bone Marrow Aspiration.

Puja Arora is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Arora is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Pulmonary Embolism.

Hira Latif is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Latif is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Protein C Deficiency, Congenital Antithrombin 3 Deficiency, and Hereditary Resistance to Anti-Vitamin K.

Hedy Smith is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Acquired Hemophilia, Anemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Mark Roschewski is a Hematologist practicing medicine in Bethesda, Maryland. Dr. Roschewski is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Smoldering Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), and Vitrectomy.

Dr. Roma Edoo-Sowah joined Inova with 21 years of medical practice experience and is board certified in internal and geriatric medicine. Prior to joining Inova, she worked in Washington, DC, as a medical director at Providence Hospital and an assistant clinical professor of medicine at George Washington University Hospital. She has a special interest in preventive medicine, hypertension and women’s health. Dr. Edoo-Sowah decided to become a physician because of her father, an internist and neurologist, who is her role model. The favorite part of her job is interacting with people from various walks of life and being involved in making a marked improvement on the physical and emotional well being of her patients. Dr. Edoo-Sowah endeavors to involve her patients in all medical decisions. She enjoys exercising, reading and traveling. Dr. Edoo is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her clinical expertise encompasses Shwartzman Phenomenon, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Venous Thromboembolism (VTE).

Nicholas Farrell is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Farrell is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia. Dr. Farrell is board certified in American Board Of Internal Medicine.

Victor Priego is a Hematologist Oncology specialist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Priego is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Anemia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Splenectomy. Dr. Priego is board certified in American Board Of Internal Medicine.